Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

(Reuters) -Elon Musk's brain implant company Neuralink is planning to raise about $500 million at a pre-money valuation of $8.5 billion, Bloomberg News reported on Wednesday, citing people with ...

In a shot across the bows of Elon Musk's rival BCI platform Neuralink, Synchron gave a presentation on the 'cognitive AI', dubbed Chiral, at the GTC 2025 event hosted by Nvidia, its development ...